| Transcriptome and translatome co-evolution in mammals ZY Wang, E Leushkin, A Liechti, S Ovchinnikova, K Mößinger, T Brüning, ... Nature 588 (7839), 642-647, 2020 | 132 | 2020 |
| Rational drug repositioning by medical genetics ZY Wang, HY Zhang Nature biotechnology 31 (12), 1080-1082, 2013 | 109 | 2013 |
| Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis ZY Wang, A Keogh, A Waldt, R Cuttat, M Neri, S Zhu, S Schuierer, ... Scientific Reports 11 (1), 1-15, 2021 | 67 | 2021 |
| The SIB Swiss Institute of Bioinformatics’ resources: focus on curated databases SIB Swiss Institute of Bioinformatics Members Nucleic acids research 44 (D1), D27-D37, 2016 | 51 | 2016 |
| Structural and energetic analyses of SNPs in drug targets and implications for drug therapy HY Sun, FQ Ji, LY Fu, ZY Wang, HY Zhang Journal of chemical information and modeling 53 (12), 3343-3351, 2013 | 30 | 2013 |
| Can medical genetics and evolutionary biology inspire drug target identification? ZY Wang, LY Fu, HY Zhang Trends in molecular medicine 18 (2), 69-71, 2012 | 26 | 2012 |
| Evolutionary and genetic features of drug targets Y Quan, ZY Wang, XY Chu, HY Zhang Medicinal research reviews 38 (5), 1536-1549, 2018 | 21 | 2018 |
| Dissecting traditional Chinese medicines by omics and bioinformatics Y Quan, ZY Wang, M Xiong, ZT Xiao, HY Zhang Natural product communications 9 (9), 1934578X1400900942, 2014 | 19 | 2014 |
| Medical genetic inspirations for anticancer drug repurposing ZY Wang, Y Quan, HY Zhang Trends in pharmacological sciences 35 (1), 1-3, 2014 | 18 | 2014 |
| Oxidative DNA damage is important to the evolution of antibiotic resistance: evidence of mutation bias and its medicinal implications ZY Wang, M Xiong, LY Fu, HY Zhang Journal of Biomolecular Structure and Dynamics 31 (7), 729-733, 2013 | 14 | 2013 |
| Loss of hepatic Lgr4 and Lgr5 promotes nonalcoholic fatty liver disease E Saponara, C Penno, V Orsini, ZY Wang, A Fischer, A Aebi, ... The American Journal of Pathology, 2022 | 11 | 2022 |
| Metabolite concentration as a criterion for antibacterial discovery ZY Wang, Q Zhu, HY Zhang Current computer-aided drug design 9 (3), 412-416, 2013 | 6 | 2013 |
Henrik KaessmannProfessor, Center for Molecular Biology, Heidelberg University在 zmbh.uni-heidelberg.de 的电子邮件经过验证
